Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210619) titled 'Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)' on Sept. 29.
Study Type: Expanded Access
Primary Sponsor: Regenerative Ocular Immunobiologics LLC
Condition:
oGVHD
Intervention:
Drug: d-MAPPS
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2026
To know more, visit https://clinicaltrials.gov/study/NCT07210619
Published by HT Digital Content Services with permission from Health Daily Digest....